Market Cap

Nanobiotix SA Market Capitalization:

€919.2 Million

EUR as of Jan. 1, 2026

US$1.08 Billion

business Nanobiotix SA Company Profile

Nanobiotix SA Main Stock Listing

Euronext: NANO

Market Capitalization History of Nanobiotix SA

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Nanobiotix SA market cap

Date Market Cap YoY Change
Jan. 1, 2026 €919.2 M 500.33%
Jan. 1, 2025 €153.1 M -54.16%
Jan. 1, 2024 €334.0 M 142.16%
Jan. 1, 2023 €137.9 M -44.32%
Jan. 1, 2022 €247.7 M -50.71%
Jan. 1, 2021 €502.6 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Nanobiotix SA Categories

France languages Healthcare languages Biotechnology
France Healthcare France Biotechnology

Stocks & Indices

Nanobiotix SA has the following listings and related stock indices.


Stock: Euronext: NANO

Stock: NASDAQ: NBTX

Stock: FSX: 5NR

Stock: FSX: 5NRA

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.